O
AGN

OppenheimerFunds’s Allergan Inc AGN Stock Holding History

OppenheimerFunds’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,597,995
Closed -$340M – 1013
2014
Q4 		$340M Sell
1,597,995
-1,453,386
-48% -$289M 0.38% 68
2014
Q3 		$544M Sell
3,051,381
-606,528
-17% -$101M 0.6% 34
2014
Q2 		$619M Sell
3,657,909
-856,205
-19% -$133M 0.69% 26
2014
Q1 		$560M Sell
4,514,114
-306,999
-6% -$37.4M 0.66% 28
2013
Q4 		$536M Buy
4,821,113
+859,723
+22% +$82.1M 0.65% 26
2013
Q3 		$358M Buy
3,961,390
+2,667,828
+206% +$239M 0.47% 47
2013
Q2 		$109M Buy
+1,293,562
New +$134M 0.16% 167

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

OppenheimerFunds's AGN Position: Q1 2015 in Review

OppenheimerFunds sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,597,995 shares — an estimated $340M sold.

OppenheimerFunds first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $619M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • OppenheimerFunds reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • OppenheimerFunds sold 1,597,995 Allergan Inc shares in Q1 2015, an estimated $340M.
  • OppenheimerFunds first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • OppenheimerFunds's Allergan Inc position peaked at $619M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.